Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 2 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 3 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 4 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 5 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 6 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 7 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 8 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 9 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 10 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 11 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 12 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 13 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 14 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 15 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 16 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 17 of 18

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution — Image 18 of 18

3D model · NIH 3D

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom resolution

Platform: NIH 3D
Price: Free
License: CC-BY; Print, modify and use commercially — credit the author.
Formats: GLBWRLX3DSTL

80 Downloads
66 Views

Author:cass condray

Published 2025-06-20

Description

PDB Classification: MEMBRANE PROTEIN

Tags

membrane protein transport protein cav1.2 channels calcium ion-selective homo sapiens

More like this

Similar models

Human L-type voltage-gated calcium channel Cav1.2 (Class II) in the presence of pinaverium at 3.2 Angstrom resolution

Human L-type voltage-gated calcium channel Cav1.2 (Class II) in the presence of pinaverium at 3.2 Angstrom resolution

NIH 3D · cass condray

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution

Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and pinaverium at 2.9 Angstrom resolution

NIH 3D · cass condray

Human L-type voltage-gated calcium channel Cav1.2 (Class I) in the presence of pinaverium at 3.0 Angstrom resolution

Human L-type voltage-gated calcium channel Cav1.2 (Class I) in the presence of pinaverium at 3.0 Angstrom resolution

NIH 3D · cass condray

Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution

Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution

NIH 3D · cass condray

Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution

Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3.3 Angstrom resolution

NIH 3D · cass condray

Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with gabapentin

Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with gabapentin

NIH 3D · cass condray

Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with L-leucine

Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with L-leucine

NIH 3D · cass condray

Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 (apo)

Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 (apo)

NIH 3D · cass condray

Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 in complex with tetrandrine (TET)

Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 in complex with tetrandrine (TET)

NIH 3D · cass condray

Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 in complex with benidipine (BEN)

Cryo-EM structure of human high-voltage activated L-type calcium channel CaV1.2 in complex with benidipine (BEN)

NIH 3D · cass condray

Solution structure of full-length apo mammalian calmodulin bound to the IQ motif of the human voltage-gated sodium channel NaV1.2

Solution structure of full-length apo mammalian calmodulin bound to the IQ motif of the human voltage-gated sodium channel NaV1.2

NIH 3D · cass condray

Single particle cryo-EM structure of the voltage-gated K+ channel Eag1 3-13 deletion mutant bound to calmodulin (conformation 2)

Single particle cryo-EM structure of the voltage-gated K+ channel Eag1 3-13 deletion mutant bound to calmodulin (conformation 2)

NIH 3D · cass condray

Names are used only to indicate the source of a result. Polyzon is not affiliated with the listed sites.